Kathryn Brown

Dr. Kathryn Brown

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
KBKathryn Brown
Kathryn Brown
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
Ludwig DuboisLudwig Dubois
Ludwig Dubois
Dirk De RuysscherDirk De Ruysscher
Dirk De Ruysscher
KPKevin Prise
Kevin Prise
Karl ButterworthKarl Butterworth
Karl Butterworth
To provide a scoping review of published studies using small animal irradiators and highlight the progress in preclinical radiotherapy (RT) studies enabled by these platforms since their development and commercialization in 2007. PubMed searches and manufacturer records were used to identify 907 studies that were screened with 359 small animal RT studies included in the analyses. These articles were classified as biology or physics contributions and into subgroups based on research aims, experimental models and other parameters to identify trends in the preclinical RT research landscape. From 2007 to 2021, most published articles were biology contributions (62%) whilst physics contributions accounted for 38% of the publications. The main research areas of physics articles were in dosimetry and calibration (24%), treatment planning and simulation (22%), and imaging (22%) and the studies predominantly used phantoms (41%) or in vivo models (34%). The majority of biology contributions were tumor studies (69%) with brain being the most commonly investigated site. The most frequently investigated areas of tumor biology were evaluating radiosensitizers (33%), model development (30%) and imaging (21%) with cell-line derived xenografts the most common model (82%). 31% of studies focused on normal tissue radiobiology and the lung was the most investigated site. This study captures the trends in preclinical RT research using small animal irradiators from 2007 to 2021. Our data show the increased uptake and outputs from preclinical RT studies in important areas of biology and physics research that could inform translation to clinical trials.

1 February 2019 in Cancers
Verified
Journal Article
Open access
PDF file
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
KBKathryn Brown
Kathryn Brown
OKOlivia J. Kelada
Olivia J. Kelada
Edward Elliot GravesEdward Elliot Graves
Edward Elliot Graves
Karl ButterworthKarl Butterworth
Karl Butterworth
Translational research aims to provide direct support for advancing novel treatment approaches in oncology towards improving patient outcomes. Preclinical studies have a central role in this process and the ability to accurately model biological and physical aspects of the clinical scenario in radiation oncology is critical to translational success. The use of small animal irradiators with disease relevant mouse models and advanced in vivo imaging approaches offers unique possibilities to interrogate the radiotherapy response of tumors and normal tissues with high potential to translate to improvements in clinical outcomes. The present review highlights the current technology and applications of small animal irradiators, and explores how these can be combined with molecular and functional imaging in advanced preclinical radiotherapy research.

20 January 2024 in Radiotherapy and Oncology
Verified
Journal Article
Open access
KBKathryn Brown
Kathryn Brown
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
BKBrianna N. Kerr
Brianna N. Kerr
LMLetitia Mohamed-Smith
Letitia Mohamed-Smith
GWGerard M. Walls
Gerard M. Walls
KBKarl T. Butterworth
Karl T. Butterworth
Radiomics is a rapidly evolving area of research that uses medical images to develop prognostic and predictive imaging biomarkers. In this study, we aimed to identify radiomics features correlated with longitudinal biomarkers in preclinical models of acute inflammatory and late fibrotic phenotypes following irradiation. Female C3H/HeN and C57BL6 mice were irradiated with 20 Gy targeting the upper lobe of the right lung under cone-beam computed tomography (CBCT) image-guidance. Blood samples and lung tissue were collected at baseline, weeks 1, 10 & 30 to assess changes in serum cytokines and histological biomarkers. The right lung was segmented on longitudinal CBCT scans using ITK-SNAP. Unfiltered and filtered (wavelet) radiomics features (n=842) were extracted using PyRadiomics. Longitudinal changes were assessed by delta analysis and principal component analysis (PCA) was used to remove redundancy and identify clustering. Prediction of acute (week 1) and late responses (weeks 20 & 30) was performed through deep learning using the Random Forest Classifier (RFC) model. Radiomics features were identified that correlated with inflammatory and fibrotic phenotypes. Predictive features for fibrosis were detected from PCA at 10 weeks yet overt tissue density was not detectable until 30 weeks. RFC prediction models trained on 5 features were created for inflammation (AUC 0.88), early-detection of fibrosis (AUC 0.79) and established fibrosis (AUC 0.96). This study demonstrates the application of deep learning radiomics to establish predictive models of acute and late lung injury. This approach supports the wider application of radiomics as a non-invasive tool for detection of radiation-induced lung complications.

18 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
KBKathryn Brown
Kathryn Brown
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
GSGiuseppe Schettino
Giuseppe Schettino
KPKevin Prise
Kevin Prise
Karl ButterworthKarl Butterworth
Karl Butterworth
BioXmark® (Nanovi A/S, Denmark) is a novel fiducial marker based on a liquid, iodine-based and non-metallic formulation. BioXmark® has been clinically validated and reverse translated to preclinical models to improve cone-beam CT (CBCT) target delineation in small animal image-guided radiotherapy (SAIGRT). However, in phantom image analysis and in vivo evaluation of radiobiological response after the injection of BioXmark® are yet to be reported. In phantom measurements were performed to compare CBCT imaging artefacts with solid fiducials and determine optimum imaging parameters for BioXmark®. In vivo stability of BioXmark® was assessed over a 5-month period, and the impact of BioXmark® on in vivo tumour response from single-fraction and fractionated X-ray exposures was investigated in a subcutaneous syngeneic tumour model. BioXmark® was stable, well tolerated and detectable on CBCT at volumes ≤10 µL. Our data showed imaging artefacts reduced by up to 84% and 89% compared to polymer and gold fiducial markers, respectively. BioXmark® was shown to have no significant impact on tumour growth in control animals, but changes were observed in irradiated animals injected with BioXmark® due to alterations in dose calculations induced by the sharp contrast enhancement. BioXmark® is superior to solid fiducials with reduced imaging artefacts on CBCT. With minimal impact on the tumour growth delay, BioXmark® can be implemented in SAIGRT to improve target delineation and reduce set-up errors.

6 September 2025 in Radiotherapy and Oncology
Verified
Journal Article
Open access
KBKathryn Brown
Kathryn Brown
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
MMMalachy P. McIvor
Malachy P. McIvor
MMMark P. McDowell
Mark P. McDowell
OMOwen McLaughlin
Owen McLaughlin
Karl ButterworthKarl Butterworth
Karl Butterworth
Preclinical evidence has demonstrated the potential of FLASH radiotherapy (FLASH-RT) to spare normal tissues compared to conventional (CONV) exposures. Most FLASH studies have used ultra-high dose rate (>40 Gy/sec) electrons and protons whilst comparatively few studies have reported photon FLASH responses. Given the widespread use of photons clinically, there is a need to characterise the FLASH effect using photons. In this study, we applied a novel photon FLASH system (FLASH-SARRP, Xstrahl) to investigate the effects of dose, dose rate and split dose on murine skin toxicity. Skin toxicity was assessed at CONV (3.2 Gy/min) and FLASH (72 Gy/s) dose rates using the SARRP or FLASH-SARRP. CONV responses were investigated at a dose of 20.2 Gy and FLASH responses at doses of 18.1, 21.3 & 25.8 Gy. Comparative studies were conducted using a split dose exposure with an average dose rate of 2.8 Gy/s. Skin toxicity on the hind leg of C57BL/6 mice was visually scored and histopathological analysis performed at 8-12 weeks. Tumour growth delay was also assessed using a melanoma (B16-F10) xenograft model irradiated at FLASH and CONV dose rates. Skin toxicity was delayed for FLASH exposures and tissue analysis showed hyperplasia and significant fibrosis deposition (p < 0.01) in CONV mice compared to FLASH. Tissue recovery was observed for both dose rates from 8 weeks post RT. A dose dependent relationship for FLASH sparing was observed, while a split dose exposure resulted in loss of sparing. FLASH was equally effective for tumour control in comparison to CONV exposures (p = 0.99). These results demonstrate it is feasible to deliver photon FLASH exposures with sparing consistent with observations from previous studies using proton and electron beams. Dose, average dose rate and beam structure are key parameters that modulate radiobiological responses to photon FLASH.

9 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
KBKathryn Brown
Kathryn Brown
JIJacob Illyuk
Jacob Illyuk
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
GWGerard M. Malachy Walls
Gerard M. Malachy Walls
CMConor K. McGarry
Conor K. McGarry
Karl ButterworthKarl Butterworth
Karl Butterworth
Radiomics image analysis has the potential to uncover disease characteristics for the development of predictive signatures and personalised radiotherapy treatment. Inter-observer and inter-software delineation variabilities are known to have downstream effects on radiomics features, reducing the reliability of the analysis. The purpose of this study was to investigate the impact of these variabilities on radiomics outputs from preclinical cone-beam computed tomography (CBCT) scans. Inter-observer variabilities were assessed using manual and semi-automated contours of mouse lungs (n = 16). Inter-software variabilities were determined between two tools (3D Slicer and ITK-SNAP). The contours were compared using Dice similarity coefficient (DSC) scores and the 95th percentile of the Hausdorff distance (HD95p) metrics. The good reliability of the radiomics outputs was defined using intraclass correlation coefficients (ICC) and their 95% confidence intervals. The median DSC scores were high (0.82–0.94), and the HD95p metrics were within the submillimetre range for all comparisons. the shape and NGTDM features were impacted the most. Manual contours had the most reliable features (73%), followed by semi-automated (66%) and inter-software (51%) variabilities. From a total of 842 features, 314 robust features overlapped across all contouring methodologies. In addition, our results have a 70% overlap with features identified from clinical inter-observer studies.